CD4 and autoimmune hepatitis: Standard AIH treatment consists of immunosuppressive therapy; however more than 70% of patients relapse when treatment withdrawal is attempted, suggesting a persistence of pathogenic cells, such as autoreactive CD4+ T cells [43, 117].